Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?FALINI, Brunangelo; GIONFRIDDO, Ilaria; CECCHETTI, Federica et al.Blood reviews. 2011, Vol 25, Num 6, pp 247-254, issn 0268-960X, 8 p.Article

Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile NeutropeniaBUCANEVE, Giampaolo; MICOZZI, Alessandra; CANTAFFA, Renato et al.Journal of clinical oncology. 2014, Vol 32, Num 14, pp 1463-1470, issn 0732-183X, 8 p.Article

Full haplotype-mismatched hematopoietic stem-cell transplantation : A phase II study in patients with acute leukemia at high risk of relapseAVERSA, Franco; TERENZI, Adelmo; ALOISI, Teresa et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3447-3454, issn 0732-183X, 8 p.Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article